Travel

Jungbunzlauer to acquire from International Flavors & Fragrances, Inc. multipurpose site in Thomson, IL

 – establishing U.S. manufacturing footprint – BASEL, Switzerland, Sept. 2, 2025 /PRNewswire/ -- Jungbunzlauer, a global leader in high-quality, sustainable…

4 hours ago

Questex’s IHIF Asia Attracts 100+ Global Investors Representing $107B AUM to Drive Hospitality Deal-Making

HONG KONG, Sept. 1, 2025 /PRNewswire/ -- Questex's International Hospitality Investment Forum (IHIF) Asia announces record-breaking participation, with 100+ leading…

16 hours ago

Asia Pacific View: Beijing Rediscovered–Where Heritage Meets Innovation, Openness Fuels the Future

BEIJING, Aug. 30, 2025 /PRNewswire/ -- Beijing, an ancient capital steeped in profound historical legacy, is radiating its distinctive charm…

4 days ago

Morphy Richards Brings “Innovate for Enlightening Progress” to IFA Berlin 2025

BERLIN, Aug. 29, 2025 /PRNewswire/ -- Morphy Richards, a trusted name in home appliances with 89 years of legacy, will…

4 days ago

IMG Shares 2025 Autumn Travel Trends: Top Destinations and Increased Spending

IMG took a sample of its customers and reviewed more than 30,000 travel itineraries of members with upcoming travel plans…

5 days ago

AIP Capital and BeYoke Capital Form Strategic Partnership

AIP Capital and BeYoke have formed a strategic partnership to originate aircraft and engine investment opportunities for Japanese investors DUBLIN…

5 days ago

ECOVACS 2024 Sustainability Report Highlights Its Commitment to Sustainability and Data Security

SUZHOU, China, Aug. 28, 2025 /PRNewswire/ -- Recently, ECOVACS (603486.SH), a global leader in service robotics, has outlined its environmental,…

5 days ago

HEXCLAD ANNOUNCES F1 DRIVER YUKI TSUNODA AS GLOBAL AMBASSADOR

Tsunoda Joins Gordon Ramsay in High-Performance Campaign Blending Speed, Precision, Culinary Excellence LOS ANGELES, Aug. 26, 2025 /PRNewswire/ -- HexClad, the…

6 days ago

Abbott receives regulatory approval for the first denosumab biosimilar in Thailand, expanding access to bone disease treatment

Abbott's denosumab biosimilar is the first approved in Thailand, making advanced therapy for osteoporosis and cancer-related bone loss more affordable for…

1 week ago

Hollyland Brings Global Creators to China for Cross-Cultural Tech and Creativity Tour

SHENZHEN, China, Aug. 25, 2025 /PRNewswire/ -- As part of its WeConnect 2025 brand day celebration, Hollyland is bringing more than…

1 week ago